Position in BMY
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$2,266,713
-$253,597 QoQ
Shares Held
39,339
-5.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#787
of 2,506 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 34%
Shared 0%
None 66%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CARRET ASSET MANAGEMENT, LLC holds $55,272,630 across 8 Drug Manufacturers - General names. BMY ranks #6 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
80,403 | $20,419,949 | |
| 2 | ABBV |
AbbVie Inc.
|
50,635 | $12,741,791 | |
| 3 | MRK |
Merck & Co., Inc.
|
78,520 | $10,089,820 | |
| 4 | LLY |
ELI LILLY & Co
|
4,753 | $5,700,891 | |
| 5 | PFE |
Pfizer Inc
|
95,897 | $2,309,199 | |
| 6 | BMY |
Bristol Myers Squibb Co
This page
|
39,339 | $2,266,713 | |
| 7 | AMGN |
Amgen Inc
|
3,979 | $1,440,875 | |
| 8 | AZN |
Astrazeneca PLC
|
1,600 | $303,392 |
All Filings in BMY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,266,713 | 39,339 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $2,520,310 | 41,555 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,395,205 | 44,405 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,317,914 | 51,395 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,273,163 | 49,107 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $3,091,400 | 50,687 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $2,823,248 | 49,916 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $2,787,078 | 53,867 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $2,315,172 | 55,747 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $3,070,339 | 56,617 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $2,941,961 | 57,337 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $3,357,207 | 57,843 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $3,693,624 | 57,758 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $4,096,221 | 59,100 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $4,888,498 | 67,943 | Shares | Sole | 2023-01-10 | |
| 2022-06-30 | $5,202,736 | 67,568 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $4,946,467 | 67,732 | Shares | Sole | 2022-04-13 | |
| 2021-12-31 | $4,199,085 | 67,347 | Shares | Sole | 2022-01-10 | |
| 2021-09-30 | $3,839,955 | 64,897 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $4,767,406 | 71,347 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $4,460,071 | 70,649 | Shares | Sole | 2021-07-14 | |
| 2020-12-31 | $4,286,210 | 69,099 | Shares | Sole | 2021-03-16 | |
| 2020-09-30 | $4,096,645 | 67,949 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $3,472,081 | 59,049 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $2,816,207 | 50,524 | Shares | Sole | 2020-05-18 | |
| No filing history on record for this holder in this stock. | ||||||